Organization · Venture Capital
Highcroft Capital
Highcroft Capital is a venture capital fund based in Wayzata, Minnesota, specializing in early-stage investments in medical technology companies. Founded by physician investors, it leverages clinical insights to evaluate and support innovations in healthcare.
Overview
What Highcroft Capital does
What Highcroft Capital is
Highcroft Capital is a venture capital fund based in Wayzata, Minnesota, specializing in early-stage investments in medical technology companies. Founded by physician investors, it leverages clinical insights to evaluate and support innovations in healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Highcroft Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Highcroft Capital as a funder
Investment thesis
Highcroft Capital focuses on early-stage investments in medtech companies, leveraging clinical insights from its physician-led team to evaluate technologies as both investors and potential users. The firm aims to advance the standard of care and facilitate access to healthcare venture opportunities.
Focus narrative
Highcroft Capital invests primarily in early-stage medical technology companies. The fund is particularly interested in game-changing products and technologies that have the potential to significantly impact the medical field. With a planned fund size of $3 million to $5 million, Highcroft Capital aims to support innovations that enhance clinical practices and improve patient outcomes.
Value beyond capital
Highcroft Capital adds value to its portfolio companies through its unique perspective as a physician-led team, providing clinical insights and validation that can enhance product development and market adoption. The firm actively engages with its portfolio companies to facilitate connections within the healthcare ecosystem and support their growth strategies.
Terms and economics
- Typical check
- $3,000,000–$5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Sectors
- Healthcare · Medical Devices
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
- Recorded notable exits
- Caption Health and Geneva Health Solutions
Portfolio context
VenstraMedical: A cardiovascular medical-device company developing a next-generation percutaneous ventricular assist device. Caption Health: An AI-guided ultrasound company, recognized as a 7x investment from Fund I. Geneva Health Solutions: A cardiac-device data-management company, noted for a 3x return from Fund I.
Common questions
What to know about Highcroft Capital
Upseed classifies Highcroft Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.